Aptus Pharma IPO
Aptus Pharma IPO
Overview
Aptus Pharma IPO is a book build issue of ₹13.02 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹13.02 crore. Aptus Pharma IPO opens for subscription on Sep 23, 2025 and closes on Sep 25, 2025. The allotment for the Aptus Pharma IPO is expected to be finalized on Sep 26, 2025. Aptus Pharma IPO will list on BSE SME with a tentative listing date fixed as Sep 30, 2025. Aptus Pharma IPO price band is set at ₹65.00 to ₹70.00 per share . The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,80,000.00 (4,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (6,000 shares), amounting to ₹4,20,000. Interactive Financial Services Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Market-Hub Stock Broking Pvt.Ltd..
Total Shares
18,60,000
Issue Size
₹13.02 Cr
Price Band
₹65 – ₹70
Lot Size
2000 shares
Min. Investment
₹2,80,000
Max. Investment
₹2,80,000
Open Date
23 Sep, 2025
Close Date
25 Sep, 2025
Allotment
26 Sep, 2025
Listing
30 Sep, 2025
Max. Investment
₹2,80,000
Announced
23 Sep, 2025
Opening Date
23 Sep, 2025
Closing Date
25 Sep, 2025
Basis of Allotment
26 Sep, 2025
Initiation of Refunds
29 Sep, 2025
Credit of Shares
29 Sep, 2025
Listing Date
30 Sep, 2025
Live GMP
Est. Listing: ₹77
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Aptus Pharma IPO
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
- Aptu
Aptus Pharma IPO Share Price
Issue Breakdown
Shareholding
Dilution: 37.2% increase in shares
Aptus Pharma IPO Promoters Holding
Aptus Pharma IPO Financial Health
Aptus Pharma Limited's revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
Aptus Pharma IPO Lot Size
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4000 | ₹2,80,000 |
| Individual investors (Retail) (Max) | 2 | 4000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 6000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 14000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 16000 | ₹11,20,000 |
(All values in CR)
Aptus Pharma IPO Valuations
The market capitalization of Aptus Pharma IPO is ₹48.02 Cr. KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| ROE | 44.50 |
| ROCE | 45.66 |
| Debt/Equity | 1.49 |
| RoNW | 44.50 |
| EBITDA Margin | 19.31 |
(All values in CR)
Aptus Pharma IPO Strength & Risk
Aptus Pharma IPO Strength:
Asset-light contract manufacturing model reducing capital expenditure and operational risks.
Diverse product portfolio across multiple therapeutic segments including anti-infectives, cardiovascular, gastrointestinal, neuro-psychiatric, and wellness products.
Established distribution network with specialized divisions and extensive sales coverage.
Strategic centralized warehousing supporting efficient supply chain.
Products manufactured by WHO-GMP certified units ensuring quality compliance.
Strong financial performance with consistent revenue and profit growth.
Aptus Pharma IPO Risk:
Dependence on third-party contract manufacturing, creating supplier risk.
High regional revenue concentration, mostly from Gujarat.
Working capital intensive business due to inventory and receivables growth.
Several product brands and corporate logo pending trademark registration.
IPO fund utilization is internally managed without third-party monitoring.
Aptus Pharma IPO GMP
Aptus Pharma SME IPO last GMP is ₹7, last updated Sep 23rd 2025 05:55 PM. With the price band of 70.00, Aptus Pharma SME IPO's estimated listing price is ₹77 (cap price + today's GMP).The expected percentage gain/loss per share is 10.00%. >> Aptus Pharma SME IPO Retail Subject to Sauda: ₹10600 The lowest GMP is ₹0.00, while the highest GMP is ₹7.00.
Last updated 23 Sep, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 23 Sep, 2025 | 70 | ₹7 | 10600 | ₹77 (10.00%) | 14000 | 23 Sep, 2025 |
| 22 Sep, 2025 | 70 | ₹7 | 10600 | ₹77 (10.00%) | 14000 | 22 Sep, 2025 |
| 21 Sep, 2025 | 70 | ₹7 | 10600 | ₹77 (10.00%) | 14000 | 21 Sep, 2025 |
| 20 Sep, 2025 | 70 | ₹7 | 10600 | ₹77 (10.00%) | 14000 | 20 Sep, 2025 |
| 19 Sep, 2025 | 70 | ₹7▲ | 10600 | ₹77 (10.00%) | 14000 | 19 Sep, 2025 |
| 18 Sep, 2025 | 70 | ₹0 | - | - | - | 18 Sep, 2025 |
| 17 Sep, 2025 | 70 | ₹0 | - | ₹70 (0.00%) | - | 17 Sep, 2025 |
| 16 Sep, 2025 | 70 | ₹0 | - | ₹ (%) | - | 16 Sep, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Aptus Pharma IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Aptus Pharma IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.